ArticleKidney & blood pressure research2019

The SGLT2 Inhibitor Empagliflozin Might Be a New Approach for the Prevention of Acute Kidney Injury.

Chang Chu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.